Bassem Elghetany

The University of Texas Medical Branch at Galveston

Papers

Total Citations

H-Index

About

Bassem Elghetany’s research focuses on virology and serological assay development, with a particular emphasis on creating practical tools to combat emerging viral threats. His major contribution lies in bridging the gap between research and clinical applications, exemplified by his work on an integrated research-clinical BSL-2 platform for a live SARS-CoV-2 neutralization assay. This platform, detailed in his most-cited paper (2023, 5 citations), utilizes a highly attenuated SARS-CoV-2 strain (Δ3678_WA1-s) to safely and efficiently monitor neutralizing antibodies against the virus and its variants of concern. By enabling reliable serological testing in a lower-containment setting, Elghetany’s work enhances accessibility for both research labs and clinical settings, directly supporting pandemic response efforts. His approach underscores a commitment to translational science, ensuring that critical diagnostic tools are both robust and widely deployable. Though early in his career, Elghetany’s contributions highlight his potential to shape future virological surveillance and vaccine efficacy studies, offering a scalable model for addressing evolving pathogens.